GWM
XERS icon

GK Wealth Management’s Xeris Biopharma Holdings XERS Stock Holding History

GK Wealth Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31.6K Buy
+3,310
New +$28K 0.02% 542

Other funds holding XERS

VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

GK Wealth Management's XERS Position: Q3 2026 in Review

GK Wealth Management opened a new position in Xeris Biopharma Holdings (XERS) in Q3 2026: 3,310 shares worth $31.6K. The stake represents 0.02% of the portfolio and ranks #542 among its holdings.

7 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • GK Wealth Management held 3,310 shares of Xeris Biopharma Holdings worth $31.6K as of Q3 2026.
  • Xeris Biopharma Holdings was a new GK Wealth Management position in Q3 2026.
  • Xeris Biopharma Holdings made up 0.02% of GK Wealth Management's portfolio in Q3 2026, its #542 holding.
  • 7 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.